Skip to main content

Jonathan L. Kravetz

Member / Chair, Securities & Capital Markets Practice; Co-chair, Life Sciences Practice

[email protected]



Jon is Chair of the Securities & Capital Markets Practice Group and Co-chair of the Life Sciences Practice Group. He represents clients in both public and privately placed equity and debt financings under the Securities Act of 1933, provides counseling for public companies with respect to the full range of securities compliance issues under the Securities Exchange Act of 1934, and advises high-technology, biotechnology, and medical device companies in numerous contractual and strategic matters.

Jon has an active international practice, representing European companies in merger and acquisition, financing, and other transactions with US and non-US companies.

He has extensive knowledge and experience in the public offering process, representing companies and underwriters in both initial and follow-on public offerings involving straight equity, debt securities, and hybrid securities, such as convertible exchangeable preferred stock, underwritten by major national, international, and regional underwriting firms with domestic and foreign tranches.

He also represents and counsels companies, both public and private, in merger and acquisition transactions, venture capital financings, and executive compensation issues.

Jon has been recognized by Chambers USA for many years, and client commentary in the publication notes, “Jonathan Kravetz is the best securities lawyer I have worked with in my career.  He’s brilliant, knowledgeable, thoughtful, client-centric and a pleasure to partner with to solve problems,” and further, “Kravetz is thoughtful, measured, wise, responsive and trustworthy.  He’s exceptional.”


  • Stanford University (JD)
  • Williams College (BA, magna cum laude, Phi Beta Kappa)

Recognition & Awards

  • Chambers Global: Life Sciences: Corporate/Commercial - USA (2020)
  • Chambers USA: Massachusetts – Corporate/M&A: Capital Markets (2010 – 2020)
  • Chambers USA: Nationwide – Life Sciences: Corporate/Commercial (2010 – 2019)
  • Best Lawyers in America: Boston Securities/Capital Markets Law Lawyer of the Year (2019, 2021)
  • Who’s Who Legal: Life Sciences: Transactional (2019)
  • Best Lawyers in America: Boston Securities Regulation Lawyer of the Year (2017)
  • Best Lawyers in America: Boston Biotechnology Law Lawyer of the Year (2014)
  • Best Lawyers in America: Biotechnology Law, Securities/Capital Markets Law, Securities Regulation, Technology Law (2006 – 2021)
  • Included on the Massachusetts Super Lawyers list: Securities & Corporate Finance (2006 – 2019)
  • Recommended by The Legal 500 United States for Healthcare: Life Sciences (2015 – 2020); Capital Markets: Equity (2020)
  • Martindale-Hubbell AV Preeminent


  • Board Member, National Consumer Law Center, Inc.
  • Member, Audit and Finance Committee of the National Consumer Law Center, Inc.
  • Member, American Bar Association
  • Member, Massachusetts Bar Association
  • Member, Boston Bar Association


Viewpoint Thumbnail

Life Sciences Newsletter — Inaugural Edition

August 20, 2020 | Article | By Adam Lenain, William Whelan, Susan Berson, Jonathan L. Kravetz, Terri Shieh-Newton

The inaugural Mintz Life Sciences Newsletter brings the latest developments in life sciences, legal insights, and industry activity straight to your inbox.
Read more

News & Press

Press Release Thumbnail
In the latest guide, Mintz garnered rankings as a top national firm in eight practice areas, and 32 firm attorneys were individually recognized.
Press Release Thumbnail
Firm plays a key role in the largest health care acquisition to date in 2020.
Press Release Thumbnail
Mintz partner and Massachusetts lawyer Julie Korostoff is one of 49 attorneys recognized as “Leaders in Their Fields” by the 2018 Chambers USA: America's Leading Lawyers for Business guide. Chambers named Korostoff a “Recognized Practitioner” in Technology.
Press Release Thumbnail
Best Lawyers named 85 Mintz attorneys to its 2018 list of The Best Lawyers in America. In addition, Mintz attorneys Matthew J. Gardella and Samuel M. Tony Starr were named “Lawyer of the Year” in their respective practice areas.
Mintz represented G1 Therapeutics, Inc. in its initial public offering of 7,781,564 shares of common stock. G1 Therapeutics is a clinical-stage biopharmaceutical company.
Fifty-three Mintz attorneys have been named Massachusetts Super Lawyers for 2016 and thirty-one have been named Massachusetts Rising Stars. The findings will be published in the November 2016 issue of Boston Magazine and in a stand-alone magazine, New England Super Lawyers. 
Attorneys from Mintz represented Myriad Genetics, Inc. in its acquisition of Assurex Health, an informatics-based precision medicine company providing treatment decision support to health care providers for mental health patients.
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Best Lawyers named 73 Mintz attorneys to its 2017 list of The Best Lawyers in America. Mintz attorneys selected for inclusion in this year’s list span 44 practice areas. 
Firm’s National Healthcare Practice, NY Corporate/M&A and Litigation: General Commercial Among Newest Rankings
The 2015 Chambers USA: America's Leading Lawyers for Business guide names 52 Mintz, Cohn, Ferris, Glovsky and Popeo, P.C.  attorneys as “Leaders in Their Fields.”